Be the leader in bone-targeted drug delivery to cure bone cancer and metastases
Atlanthera has been developing a robust pipeline and is generating product candidates designed to provide durable efficacy .
Our focus on the rare diseases and on the patient is supported by preclinical and clinical development expertise and internal capabilities in compound optimization, chemical synthesis and in-vitro and in-vivo assay development.
Our Key figures:
You would like to become a financial partner of Atlanthera Company? Please feel free to contact us >